Is Venu VENU building a durable competitive moat Softens 20260508 What is pushing Global GIC stock higher Q4 1999 EPS Beats Forecasts Why GCL Global GCL ability to execute stands out Recovers 20260508 CTNM Q1 2026 Earnings EPS Surprise Beats Estimates Stock Rises Amid RD Progress Palladyne AI PDYN Q1 2026 Earnings Miss EPS 023 vs 017 Expected Blackstone and Google Join Forces on 5 Billion AI Infrastructure Venture Powered by TPU Chips ECBs Rehn Signals Limited Evidence of Sustained High Inflation Pressures Taiwan Emerges as Central Flashpoint in TrumpXi Talks Crypto Middlemen in China Sidestep Crackdown Amid Trade Surge SEBI Chief Tuhin Kanta Pandey Indias Market Diversification Remains Key Advantage Over Taiwans Concentrated Growth MuskAltman Trial Could Boost AI Industry Transparency Disneys The Mandalorian and Grogu Opens to Weakest Star Wars Box Office Could This Signal Franchise Fatigue PB Fintech Cofounders Plan 6536 Crore Share Sale via Block Deal Rapport Therapeutics Inc RAPP Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Gain IQ Q1 2026 Earnings EPS Miss Weighs on Shares as iQIYI Navigates Challenging Landscape RYAAY Q1 2026 Earnings WiderThanExpected Loss Amidst Operational Challenges NSA Q1 2026 Earnings EPS Beats Estimates by 56 Amid Steady SelfStorage Fundamentals The9 Limited NCTY Q1 2012 Earnings NarrowerThanExpected Loss Signals Cost Discipline Amid Revenue Uncertainty Adagene Inc Q2 2025 Earnings EPS Miss Amid Continued RD Investment Olema Pharmaceuticals OLMA Tests Key Support Amid Broad Market Pressure Armata Pharmaceuticals ARMP Edges Higher Stock Holds Near Key Resistance After Modest Gain Green Brick Partners GRBK Edges Higher as Homebuilder Shows Resilience Near Resistance China SXT Pharmaceuticals SXTC Slips 3 as Stock Tests Key Support Levels Sunshine Biopharma SBFM Edges Higher as Shares Hold Above Key Support at 040 Kotak Warns FPI Flows to India May Stay Subdued as Emerging Market Appeal Fades On Holding AG ONON Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment Clene Inc CLNN Faces Pressure Support Levels in Focus After 4 Decline